MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • MDS Virtual Congress 2020

    Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador

    J. Lopez-Castellanos, J. Lopez Contreras (Little Rock, AR, USA)

    Objective: To Evaluate the therapeutic and preventive effect of OnabotulinumtoxinA in the treatment of trigeminal neuralgia (TN) and chronic migraine (CM) in patients with bilateral…
  • MDS Virtual Congress 2020

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study

    B. Bergmans, V. Schotte, N. Sys, E. Van Massenhove, M. Van Zandijcke (Brugge, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles into the…
  • MDS Virtual Congress 2020

    Refining Knowledge on the Treatment of Pisa Syndrome with Botulinum Toxin

    C.A Artusi, F. Marchet, U. Dimanico, C. Zanella, M. Zibetti, A. Merola, G. Massazza, L. Lopiano (Torino, Italy)

    Objective: To analyze the efficacy of botulinum toxin (BoNT) in cases of pisa syndrome (PS) associated with Parkinson's disease (PD) targeting paraspinal muscles ipsilateral to…
  • MDS Virtual Congress 2020

    Effectiveness of onabotulinumtoxinA on reduction of rest tremor in Parkinson’s disease: A pilot study

    D. Roque, D. Drazheva, N. Browner, M. Sklerov, M. Collins (Chapel Hill, NC, USA)

    Objective: To determine the feasibility of a prospective study design aimed specifically at comparing the effect of onabotulinumtoxinA (BOT-A) to placebo injections on persons with…
  • MDS Virtual Congress 2020

    Painful Legs and Moving Toes (PLMT): A Case Series

    N. Labaure, I. Amorin, A. Lescano, G. Morando (Montevideo, Uruguay)

    Objective: Describe and characterize our PLMT patients in terms of clinical presentation, neurophysiology, imaging, associated conditions and response to treatment. Background: First described by Spillane…
  • MDS Virtual Congress 2020

    Ultrasound-guided treatment of action tremor of the upper limb with botulinum toxin

    M.C Costa, P. Pita-Lobo, C. Figueiredo, L. Rebordão, A. Cadete (Amadora, Portugal)

    Objective: To assess the functional benefit of ultrasound-guided treatment with botulinum toxin type A in patients with action tremor of the upper limb. Background: Action…
  • MDS Virtual Congress 2020

    Botulinum Toxin Injections for Upper Limb Dystonia with Tremor

    R. Rajan, R. Anandapadmanabhan, A. Saini, V.Y Venugopalan, A. Gupta, R. Bhatia, M. Singh, A. Srivastava, P. Srivastava (New Delhi, India)

    Objective: To study the effect of BoNT injections on tremor in patients with upper limb dystonia with hand tremor. Background: Tremor is a common accompaniment…
  • MDS Virtual Congress 2020

    Use of Botulinum Toxin: Experience in a Cohort of Essential Tremor Patients

    C. Shah, F. Jamal, A. Sarwar, G. Jackson (Houston, TX, USA)

    Objective: To review the treatment characteristics of botulinum toxin in medically refractory essential tremor (ET). Background: Treatment of medically refractory essential tremor has remained challenging…
  • MDS Virtual Congress 2020

    Pregnancy Outcomes Following Exposure to OnabotulinumtoxinA Update – 29 Years of Safety Observation

    M. Brin, A. Adams, L. Parker, A. Ukah, L. Radulian, L. Yedigarova, I. Yushmanova (Irvine, CA, USA)

    Objective: The present study evaluated pregnancy outcomes following onabotulinumtoxinA exposure to provide a cumulative 29-year safety update. Background: A previous publication of pregnancy outcomes in…
  • 2019 International Congress

    The short-term effect of combined facial exercise with botulinum toxin A injection in clinical practice in Thai patients with hemifacial spasm: A randomized controlled pilot crossover study

    P. Soontrapa, Y. Pitakpatapee, A. Suengtaworn, J. Srikajon, T. Sangpeamsook, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the efficacy of combined facial exercise with BTX-A injection with BTX-A injection alone measured by the total HFS-30 (tHFS-30) score. Background: Hemifacial…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 13
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley